Compare SBSI & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SBSI | INMD |
|---|---|---|
| Founded | 1960 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 936.3M | 861.7M |
| IPO Year | 1995 | 2018 |
| Metric | SBSI | INMD |
|---|---|---|
| Price | $30.58 | $13.26 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $35.50 | $16.75 |
| AVG Volume (30 Days) | 95.0K | ★ 951.8K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.29 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.87 | $1.70 |
| Revenue Next Year | $5.82 | $3.99 |
| P/E Ratio | $13.68 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.85 | $13.16 |
| 52 Week High | $34.37 | $19.78 |
| Indicator | SBSI | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.49 | 34.62 |
| Support Level | $27.73 | N/A |
| Resistance Level | $31.60 | $14.80 |
| Average True Range (ATR) | 0.79 | 0.32 |
| MACD | -0.21 | -0.12 |
| Stochastic Oscillator | 14.02 | 1.93 |
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.